Opioids

Bind to opioid receptors to produce analgesia and euphoria. e.g., morphine, heroin, fentanyl.

The role of UK alcohol and drug (AOD) nurses in a changing workforce

Scientific article

Background: This article shares findings from a study that looked into how alcohol and other drugs (AOD) nurses in the UK view their current career opportunities and the challenges they face. It also explores how changes in health services...

Approach and Management to Newborns with Prenatal Opioid Exposure

9 May 2025

Washington DC

United States

Join Dr. Alison Sweeney of UNC Chapel Hill for an insightful session covering how to recognise signs and symptoms of opioid exposure in infants. The webinar will discuss strategies (including Eat, Sleep, Console) and team-based care to support families.

Approach and Management to Newborns with Prenatal Opioid Exposure

The American Association for the Treatment of Opioid Dependence Conference 2025

4 October 2025

Philadelphia

United States

The American Association for the

"Addressing Underlying Trauma in Opioid Use" with speaker Tanya Saraiya, PhD

22 April 2025

Washington, DC

United States

Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organisation staff

Scientific article

2 April 2025

Background Many people who could benefit from medications for opioid use disorder (MOUD) aren’t receiving them. This study looks at how MOUD agencies in Kentucky are experiencing changes in patient numbers and the challenges and supports...

European Drugs Summer School (EDSS) 2025

23 June 2025

Lisbon

Portugal

Illicit drugs in Europe: demand, supply and public policies

Special Focus on Synthetic Opioids

Our two week in-person Summer School (23rd of June to 04th of July 2025) prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs. Teaching staff include scientific experts from the EUDA, researchers, practitioners and policymakers.

VCU researchers are developing a long-acting medication for opioid addiction

News

Researchers at Virginia Commonwealth University (VCU) have developed a new version of a medication for opioid use disorder that could offer longer-lasting treatment. Current medications for opioid addiction often require daily doses, but...

Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder

Scientific article

18 February 2025

Background The opioid epidemic in the U.S. contributes to increased morbidity and mortality from drug overdoses, but barriers to traditional opioid use disorder (OUD) treatment limit access to care. During the COVID-19 pandemic, Public...

Substance Use Monitoring and Surveillance: Challenges faced by LMICs

Opinion piece, commentary

24 January 2025

Substance use surveillance has emerged as a crucial public health strategy across Africa, particularly in light of the alarming rise in substance use among adolescents (1). This trend poses significant health risks that require a...